Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Aug 1;154(8):725-736.
doi: 10.1001/jamasurg.2019.0995.

Association Between Use of Enhanced Recovery After Surgery Protocol and Postoperative Complications in Colorectal Surgery: The Postoperative Outcomes Within Enhanced Recovery After Surgery Protocol (POWER) Study

Javier Ripollés-Melchor  1   2   3   4 , José M Ramírez-Rodríguez  3   4   5 , Rubén Casans-Francés  3   4   6 , César Aldecoa  3   4   7 , Ane Abad-Motos  1   2   3   4 , Margarita Logroño-Egea  3   8 , José Antonio García-Erce  3   4   9   10 , Ángels Camps-Cervantes  11 , Carlos Ferrando-Ortolá  3   4   12 , Alejandro Suarez de la Rica  3   4   13 , Ana Cuellar-Martínez  4   14 , Sandra Marmaña-Mezquita  15 , Alfredo Abad-Gurumeta  1   2   4 , José M Calvo-Vecino  3   4   16 ; POWER Study Investigators Group for the Spanish Perioperative Audit and Research Network (REDGERM)
Affiliations
Comparative Study

Association Between Use of Enhanced Recovery After Surgery Protocol and Postoperative Complications in Colorectal Surgery: The Postoperative Outcomes Within Enhanced Recovery After Surgery Protocol (POWER) Study

Javier Ripollés-Melchor et al. JAMA Surg. .

Erratum in

Abstract

Importance: Enhanced Recovery After Surgery (ERAS) care has been reported to be associated with improvements in outcomes after colorectal surgery compared with traditional care.

Objective: To determine the association between ERAS protocols and outcomes in patients undergoing elective colorectal surgery.

Design, setting, and participants: The Postoperative Outcomes Within Enhanced Recovery After Surgery Protocol (POWER) Study is a multicenter, prospective cohort study of 2084 consecutive adults scheduled for elective colorectal surgery who received or did not receive care in a self-declared ERAS center. Patients were recruited from 80 Spanish centers between September 15 and December 15, 2017. All patients included in this analysis had 1 month of follow-up.

Exposures: Colorectal surgery and perioperative management were the exposures. Twenty-two individual ERAS items were assessed in all patients, regardless of whether they were included in an established ERAS protocol.

Main outcomes and measures: The primary study outcome was moderate to severe postoperative complications within 30 days after surgery. Secondary outcomes included ERAS adherence, mortality, readmissions, reoperation rates, and hospital length of stay.

Results: Between September 15 and December 15, 2017, 2084 patients were included in the study. Of these, 1286 individuals (61.7%) were men; mean age was 68 years (interquartile range [IQR], 59-77). A total of 879 patients (42.2%) presented with postoperative complications and 566 patients (27.2%) developed moderate to severe complications. The number of patients with moderate or severe complications was lower in the ERAS group (25.2% vs 30.3%; odds ratio [OR], 0.77; 95% CI, 0.63-0.94; P = .01). The overall rate of adherence to the ERAS protocol was 63.6% (IQR, 54.5%-77.3%), and the rate for patients from hospitals self-declared as ERAS was 72.7% (IQR, 59.1%-81.8%) vs non-ERAS institutions, which was 59.1% (IQR, 50.0%-63.6%; P < .001). Adherence quartiles among patients receiving the highest and lowest ERAS components showed that the patients with the highest adherence rates had fewer moderate to severe complications (OR, 0.34; 95% CI, 0.25-0.46; P < .001), overall complications (OR, 0.33; 95% CI, 0.26-0.43; P < .001), and mortality (OR, 0.27; 95% CI, 0.07-0.97; P = .06) compared with those who had the lowest adherence rates.

Conclusions and relevance: An increase in ERAS adherence appears to be associated with a decrease in postoperative complications.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Ripollés-Melchor reports personal fees from Edwards Lifesciences and Fresenius Kabi outside the submitted work. Dr García-Erce reports personal fees from Alexion, Amgen, Braun, Celgene, Ferrer, GSK, Inmucor, Jansen, Novartis, Octapharma, Sanofi, Sandoz, Terumo and Zambon; and personal fees and nonfinancial support from Vifor Pharma outside the submitted work. Dr Suarez de la Rica reports personal fees from Baxter and MSD outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. STROBE Flow Diagram for Included Patients
Figure 2.
Figure 2.. Postoperative Outcomes
Moderate or severe complications and type of complication in all included patients and in patients with and without the Enhanced Recovery After Surgery (ERAS) protocol. aStatistically significant.
Figure 3.
Figure 3.. Postoperative Outcomes and Enhanced Recovery After Surgery (ERAS) Adherence
Postoperative moderate to severe complications in all included patients depending on the quartile (Q) of adherence to the ERAS protocol. aStatistically significant.
Figure 4.
Figure 4.. Moderate to Severe Complications by Enhanced Recovery After Surgery (ERAS Items)
PONV indicates postoperative nausea and vomiting. aStatistically significant.
See this image and copyright information in PMC

Comment in

References

    1. Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. Lancet. 2015;385(suppl 2):S11. doi: 10.1016/S0140-6736(15)60806-6 - DOI - PubMed
    1. International Surgical Outcomes Study group Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016;117(5):601-609. doi: 10.1093/bja/aew316 - DOI - PMC - PubMed
    1. Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: a study of 12,075 patients. Ann Surg. 2015;261(3):497-505. doi: 10.1097/SLA.0000000000000854 - DOI - PubMed
    1. Govaert JA, Fiocco M, van Dijk WA, et al. ; Dutch Value Based Healthcare Study Group . Costs of complications after colorectal cancer surgery in the Netherlands: building the business case for hospitals. Eur J Surg Oncol. 2015;41(8):1059-1067. doi: 10.1016/j.ejso.2015.03.236 - DOI - PubMed
    1. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DAJ Jr. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004;199(4):531-537. doi: 10.1016/j.jamcollsurg.2004.05.276 - DOI - PubMed

Publication types